OSIR

Osiris Therapeutics, Inc. News Headlines

$12.99
*  
0.26
2.04%
Get OSIR Alerts
*Delayed - data as of Sep. 16, 2014  -  Find a broker to begin trading OSIR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

AstraZeneca to Revamp R&D Structure - Analyst Blog
3/19/2013 5:47:17 PM - Zacks.com

Cell Therapy Leader Stephen Potter Talks Osiris, NeoStem And The Industry Itself
3/19/2013 9:15:00 AM - Seeking Alpha

Theravance Inks Deal for Vibativ - Analyst Blog
3/18/2013 4:44:02 PM - Zacks.com

BioLineRx to Initiate HCV Study - Analyst Blog
3/15/2013 4:45:23 PM - Zacks.com

Alexion Pharma Upgraded to Outperform - Analyst Blog
3/15/2013 2:48:02 PM - Zacks.com

The Stem Cell Revolution Can Jump Start Your Portfolio: Jason Kolbert
3/15/2013 11:20:00 AM - Seeking Alpha

Peregrine Reports Narrower Loss - Analyst Blog
3/13/2013 6:14:18 PM - Zacks.com

Biogen Files Hemophilia B Application - Analyst Blog
3/13/2013 4:09:18 PM - Zacks.com

Major Setback for Aeterna Zentaris - Analyst Blog
3/12/2013 7:13:03 PM - Zacks.com

Acorda Presents GGF2 Data - Analyst Blog
3/8/2013 5:15:01 PM - Zacks.com

Osiris Wows The Market With Stellar Earnings Report
3/8/2013 4:54:00 PM - Seeking Alpha

Narrower-Than-Expected Loss at OSIR - Analyst Blog
3/7/2013 9:30:01 AM - Zacks.com

Osiris Therapeutics: A Few Things To Consider As Earnings Trump Estimates
3/7/2013 1:44:00 AM - Seeking Alpha

Market Wrap for Wednesday, March 6: Stocks Close Mixed as Euro Tests Key Support Level Ahead of ECB Meeting
3/6/2013 5:09:25 PM - Benzinga

2012 Stem Cell Standouts And The Outlook For 2013
2/28/2013 2:15:00 PM - Seeking Alpha

Acute Radiation Syndrome, Are We Prepared And Who Is Best Preparing Us?
2/27/2013 9:40:00 AM - Seeking Alpha

Osiris Therapeutics On The Brink: Products Failing To Deliver
2/20/2013 4:12:00 PM - Seeking Alpha

2 Regenerative Medicine Plays For 2013
2/13/2013 3:36:00 PM - Seeking Alpha

Stem Cell Therapy Companies: Underappreciated Outperformers
1/29/2013 8:40:00 AM - Seeking Alpha

Stem Cell Companies For Consideration In 2013
1/9/2013 6:35:00 AM - Seeking Alpha

2012 Breakthroughs In Cell Therapy Development
1/7/2013 9:13:00 AM - Seeking Alpha

With Osiris Overvalued, NeoStem Is A Better Buy
1/2/2013 10:28:00 AM - Seeking Alpha

Mid-Week Biopharma Catalyst Trades To Consider
12/13/2012 9:35:00 AM - Seeking Alpha

Orphan Status Update from Pluristem - Analyst Blog
11/27/2012 7:00:01 PM - Zacks.com

Osiris Therapeutics: Still The Best Bet In Regenerative Medicine
11/27/2012 3:49:00 PM - Seeking Alpha